A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy
Clinical trial NCT07487896 · RECRUITING
Trial details
- NCT number
- NCT07487896
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2028-04-30
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.